Literature DB >> 15699372

Family-based case-control study of cigarette smoking and Parkinson disease.

W K Scott1, F Zhang, J M Stajich, B L Scott, M A Stacy, J M Vance.   

Abstract

OBJECTIVE: To determine whether people with Parkinson disease (PD) are less likely to report a history of cigarette smoking than their unaffected siblings.
BACKGROUND: Previous studies reported that individuals with PD are half as likely to have smoked as those unaffected by PD. Other studies reported that smoking modified the risk of PD due to polymorphisms in the MAO-B and nNOS genes. Thus, genetic studies of PD should consider confounding or interaction with smoking history as well. The authors have collected detailed smoking histories on a family-based case-control sample ascertained for genetic studies of PD.
METHODS: In a matched case-control study of 140 sibships, individuals with PD (n = 143) were compared to sibling controls (n = 168). Cigarette smoking history was collected by a structured telephone interview. Conditional logistic regression was used to examine the relationship between smoking and PD while controlling for confounding by age and sex.
RESULTS: Ever smoking, current smoking, and increasing duration (in years), dose (in packs/day), and intensity (in pack-years) of smoking were significantly inversely associated with PD (p < 0.05). The association was not modified by sex, age at onset, or recency of exposure.
CONCLUSIONS: Consistent with previous studies, individuals with Parkinson disease are significantly less likely to have smoked regularly than their unaffected siblings. This association was detected even though discordant sibling pairs are more likely to be overmatched for environmental exposures than unmatched case and control groups.

Entities:  

Mesh:

Year:  2005        PMID: 15699372     DOI: 10.1212/01.WNL.0000150905.93241.B2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Authors:  Joanna S Fowler; Jean Logan; Nora D Volkow; Gene-Jack Wang
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

2.  Clinical and pathologic features of familial interstitial pneumonia.

Authors:  Mark P Steele; Marcy C Speer; James E Loyd; Kevin K Brown; Aretha Herron; Susan H Slifer; Lauranell H Burch; Momen M Wahidi; John A Phillips; Thomas A Sporn; H Page McAdams; Marvin I Schwarz; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

3.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

4.  Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.

Authors:  N Hosseini Tabatabaei; B Babakhani; A Hosseini Tabatabaei; Z Vahabi; A Soltanzadeh
Journal:  Funct Neurol       Date:  2013 Apr-May

5.  Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement.

Authors:  G A Rippon; M X Tang; J H Lee; R Lantigua; M Medrano; R Mayeux
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

6.  Vitamin D from different sources is inversely associated with Parkinson disease.

Authors:  Liyong Wang; Marian L Evatt; Lizmarie G Maldonado; William R Perry; James C Ritchie; Gary W Beecham; Eden R Martin; Jonathan L Haines; Margaret A Pericak-Vance; Jeffery M Vance; William K Scott
Journal:  Mov Disord       Date:  2014-12-27       Impact factor: 10.338

Review 7.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

Review 8.  Nicotine and Parkinson's disease: implications for therapy.

Authors:  Maryka Quik; Kathryn O'Leary; Caroline M Tanner
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

9.  Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.

Authors:  Maurizio F Facheris; Nicole K Schneider; Timothy G Lesnick; Mariza de Andrade; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

10.  Smoking status over two years in patients with multiple sclerosis.

Authors:  Ruth Ann Marrie; Gary Cutter; Tuula Tyry; Denise Campagnolo; Timothy Vollmer
Journal:  Neuroepidemiology       Date:  2008-11-12       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.